Contribution ofBordetella bronchisepticaFilamentous Hemagglutinin and Pertactin to Respiratory Disease in Swine [PDF]
Infection and Immunity, 2009 ABSTRACTBordetella bronchisepticais pervasive in swine populations and plays multiple roles in respiratory disease. Most studies addressing virulence factors ofB. bronchisepticaare based on isolates derived from hosts other than pigs. Two well-studied virulence factors implicated in the adhesion process are filamentous hemagglutinin (FHA) and pertactin
Tracy L. Nicholson +2 more
openalex +4 more sources
Production and characterization of recombinant pertactin, fimbriae 2 and fimbriae 3 from
BMC Microbiology, 2009 Background Bordetella pertussis is a causative agent of pertussis or whooping cough in humans. Pertactin (Prn), fimbriae 2 (Fim2) and fimbriae 3 (Fim3) of B.
Hou Qiming +7 more
doaj +2 more sources
PROTECTIVE EFFICACY OF PERTACTIN CONTAINING ACELLULAR DPT VACCINES
Вопросы современной педиатрии, 2008 Pertussis vaccination with the use of DPT vaccines is a necessary condition for fighting the infection called bordetella pertussis. At the same time, it is known that the use of whole cellular DPT vaccines is accompanied with high incidence of side effects and serious neurological complications, and, as a result, reasonable refuse from injections by ...
M.V. Fesenko, Leyla S. Namazova-Baranova
openalex +3 more sources
P69 pertactin: LRR, PRR and efficacious vaccine [PDF]
Acta Crystallographica Section A Foundations of Crystallography, 1996 Paul Emsley +3 more
openalex +2 more sources
Quantitative bead-based multiplex assay for simultaneous determination of IgG concentrations of pertussis toxin, filamentous hemagglutinin, pertactin, diphtheria, tetanus, Haemophilus influenzae b, and hepatitis B in human serum samples. [PDF]
Front ImmunolRathod V +18 more
europepmc +3 more sources
As pertussis returns to pre-COVID19 endemicity, vaccination remains our best ally against an evolving Bordetella pertussis [PDF]
Emerging Microbes and InfectionsZeng Mei, Macina Denis
doaj +2 more sources
Microbiology and Immunology, Volume 67, Issue 6, Page 314-317, June 2023., 2023 Abstract Bordetella pertussis causes pertussis, which is characterized by paroxysmal coughing. This disease is generally prevented through vaccination; however, the number of pertussis cases is increasing worldwide despite high vaccination coverage. We previously reported that an autotransporter of B.
Koichiro Suzuki +3 more
wiley +1 more source
Clinical Manifestations and Molecular Characterization of Pertactin-Deficient and Pertactin-ProducingBordetella pertussisin Children, Philadelphia 2007–2014 [PDF]
Clinical Infectious Diseases, 2016 Bordetella pertussis strains lacking expression of pertactin, a bacterial adhesin and vaccine target, are emerging. There are limited data on disease manifestations of mutant strains in children. We sought to compare clinical manifestations of pertactin-deficient and pertactin-producing B.
Jennifer, Vodzak +4 more
openaire +2 more sources
Modeling the effect of oxidative stress on Bordetella pertussis fermentations
Biotechnology Progress, Volume 39, Issue 3, May/June 2023., 2023 Abstract A mathematical model is proposed for Bordetella pertussis with the main goal to better understand and describe the relation between cell growth, oxidative stress and NADPH levels under different oxidative conditions. The model is validated with flask experiments conducted under different conditions of oxidative stress induced by high initial ...
Michael Vitelli +3 more
wiley +1 more source
Journal of Tropical Medicine, Volume 2022, Issue 1, 2022., 2022 The objective of this meta‐analysis is to assess the safety and immunogenicity of maternal pertussis vaccination based on randomized clinical trials. PubMed, Embase, Cochrane Library, Web of Science, China National Knowledge Internet, and Wan Fang Database were searched from inception up to the 8th of October 2021, using a protocol registered on ...
Aidibai Simayi +3 more
wiley +1 more source